Laura García‐Estévez
The University of Texas MD Anderson Cancer Center(US)Instituto de Salud Carlos III(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)MD Anderson Cancer Center Madrid(ES)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Estrogen and related hormone effects
Most-Cited Works
- → Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast Cancer(2018)492 cited
- → Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial(2017)467 cited
- → Enhancing global access to cancer medicines(2020)203 cited
- → Updating the role of obesity and cholesterol in breast cancer(2019)163 cited
- → Results from a phase 2 study of enzalutamide (ENZA), an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC).(2015)150 cited
- → Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status(2021)147 cited